01858 CHUNLI MEDICAL
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 5.20X | Oper Margin | 16.5% |
---|---|---|---|
LT Debt/Equity | 0.0% | Net Margin | 15.5% |
Total Debt/Equity | 0.0% | Return on Equity | 4.4% |
Price/Book | 1.92X | Return on Assets | 3.6% |
(HKD 15.080) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 132.92 | 306.22 | 345.01 | 394.28 | 336.31 |
---|---|---|---|---|---|
Net Profit Growth (%) | -56.6 | -11.3 | -12.5 | +17.2 | +27.1 |
Earnings Per Share (HKD) | 0.347 | 0.798 | 0.9 | 1.14 | 0.972 |
Earnings Per Share Growth (%) | -56.6 | -11.3 | -21.1 | +17.2 | +27.9 |
Dividend Per Share (HKD) | 0.145 | 0.397 | 0.342 | 0.153 | No dividend |
P/E* (X) | 43.52 | 18.89 | 16.76 | 13.23 | 15.51 |
Yield (%) | 0.96 | 2.63 | 2.27 | 1.01 | N/A |
Dividend Share (%) | 41.88 | 49.73 | 38.01 | 13.39 | N/A |
Book NAV (HKD) | 7.836 | 8.269 | 7.935 | 7.859 | 3.705 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
Cover Period (mths) | 3 | 3 | NA | 3 |
---|---|---|---|---|
Turnover | 229.844 | 221.85 | +3.6 | 246.355 |
Operating Result | 64.503 | 59.325 | +8.7 | 62.342 |
Profit Before Taxation | 64.487 | 60.165 | +7.2 | 62.225 |
Taxation | 6.456 | 5.058 | +27.6 | 6.364 |
Profit /( Loss) After Taxation | 58.031 | 55.107 | +5.3 | 55.861 |
Minority Interests | -0.041 | -0.093 | -55.9 | 0 |
Net Profit | 58.071 | 55.2 | +5.2 | 55.861 |
Earnings Per Share () | 0.1609 | 0.1516 | +6.1 | 0.1715 |
Announcement Date | 2025-04-29 | 2024-04-29 | NA | 2023-04-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25